Filing Details
- Accession Number:
- 0001654954-17-006535
- Form Type:
- 13G Filing
- Publication Date:
- 2017-07-19 08:01:08
- Filed By:
- Stetson John
- Company:
- Innoveren Scientific Inc. (NASDAQ:IVRN)
- Filing Date:
- 2017-07-19
- SEC Url:
- 13G Filing
Ownership Summary
Please notice the below summary table is generated without human intervention and may contain errors. Please refer to the complete filing displayed below for exact figures.
| Name | Sole Voting Power | Shared Voting Power | Sole Dispositive Power | Shared Dispositive Power | Aggregate Amount Owned Power | Percent of Class |
|---|---|---|---|---|---|---|
| HS Contrarian Investments | 1,098,901 | 1,098,901 | 9 | 1,098,901 | 5.3% | |
| John Stetson | 1,098,901 | 1,098,901 | 9 | 1,098,901 | 5.3% |
Filing
SECURITIES AND
EXCHANGE COMMISSION
WASHINGTON, DC
20549
SCHEDULE
13G
(Rule
13d-102)
INFORMATION
TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO
RULE 13d-1(b) (c), AND (d) AND AMENDMENTS THERETO FILED PURSUANT
TO
RULE
13d-2(b)
MEDOVEX
CORP.
(Name
of Issuer)
COMMON STOCK, PAR
VALUE $0.001 PER SHARE
(Title of Class of
Securities)
58504H101
(CUSIP
Number)
Sichenzia
Ross Ference Kesner LLP
61 Broadway, 32nd Floor
New York, New York 10006
(Name, Address and Telephone Number of Person
(Name, Address and Telephone Number of Person
Authorized to
Receive Notices and Communications)
July 14,
2017
(Date
of Event Which Requires Filing of This Statement)
Check
the appropriate box to designate the rule pursuant to which this
Schedule is filed:
[ ]
Rule 13d-1(b)
[X]
Rule 13d-1(c)
[ ]
Rule 13d-1(d)
| CUSIP
No. 58504H101 |
| 1 | NAME OF
REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY) HS
Contrarian Investments, LLC |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A
GROUP* (a) ☐
(b)
☐ |
| 3 | SEC USE
ONLY |
| 4 | CITIZENSHIP OR
PLACE OF ORGANIZATION Delaware |
| NUMBER
OF SHARES | 5 | SOLE
VOTING POWER 1,098,901
[1] |
| BENEFICIALLY OWNED
BY | 6 | SHARED
VOTING POWER |
| EACH REPORTING | 7 | SOLE
DISPOSITIVE POWER 1,098,901
[1] |
| PERSON
WITH | 8 | SHARED
DISPOSITIVE POWER |
| 9 | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,098,901
[1] |
| 10 | CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES ☐ |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.3%
(Based on
20,922,634 shares of common stock
outstanding as of July 17, 2017) |
| 12 | TYPE OF
REPORTING PERSON CO |
(1)
Excludes two
warrants held by Stetson Capital Investments, Inc. to purchase an
aggregate of 95,288 shares of common stock, par value $0.001 per
share (“Shares”), of Medovex Corp. (the
“Issuer”), two warrants held by John Stetson to
purchase an aggregate of 37,929 Shares and a warrant acquired by HS
Contrarian Investments, LLC in this transaction to purchase 549,451
Shares which will become exercisable in January 2018. The exercise
of the warrants is subject to a beneficial ownership limitation in
accordance with which the beneficial holder of the warrants shall
not own more than 4.99% of the number of the Shares outstanding
immediately after giving effect to the issuance of the Shares
underlying the warrants. John Stetson is the control person of
Stetson Capital Investments, Inc. and HS Contrarian Investments,
LLC.
| CUSIP
No. 58504H101 |
| 1 | NAME OF
REPORTING PERSONS S.S. OR
I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES
ONLY) John
Stetson |
| 2 | CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) ☐
(b)
☐ |
| 3 | SEC USE
ONLY |
| 4 | CITIZENSHIP OR
PLACE OF ORGANIZATION United
States |
| NUMBER
OF SHARES | 5 | SOLE
VOTING POWER 1,098,901
[1][2] |
| BENEFICIALLY OWNED
BY | 6 | SHARED
VOTING POWER |
| EACH REPORTING | 7 | SOLE
DISPOSITIVE POWER 1,098,901 [1]
[2] |
| PERSON
WITH | 8 | SHARED
DISPOSITIVE POWER |
| 9 | AGGREGATE AMOUNT
BENEFICIALLY OWNED BY EACH REPORTING PERSON 1,098,901
[1][2] |
| 10 | CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN
SHARES ☐ |
| 11 | PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW 9 5.3%
(Based on
20,922,634 shares of common stock
outstanding as of July 17, 2017) |
| 12 | TYPE OF
REPORTING PERSON IN |
(1)
Includes 1,098,901
Shares held by HS Contrarian Investments, LLC of which John Stetson
is the beneficial owner and control person.
(2)
Excludes two
warrants held by John Stetson to purchase an aggregate of 37,929
Shares of the Issuer, two warrants held by Stetson Capital
Investments, Inc. to purchase an aggregate of 95,288 Shares of the
Issuer and a warrant acquired by HS Contrarian Investments, LLC in
this transaction to purchase 549,451 Shares which will become
exercisable in January 2018. The exercise of the warrants is
subject to a beneficial ownership limitation in accordance with
which the beneficial holder of the warrants shall not own more than
4.99% of the number of the Shares outstanding immediately after
giving effect to the issuance of the Shares underlying the
warrants. John Stetson is the control person of Stetson Capital
Investments, Inc.
Item
1(a).
Name of
Issuer:
Medovex
Corp., a Nevada corporation (“Issuer”)
Item
1(b).
Address of Issuer's
Principal Executive Offices:
3279 Hardee Avenue
Atlanta, Georgia 30341
Item
2(a).
Name of Person
Filing.
This
statement is filed on behalf of HS Contrarian Investments, LLC and
John Stetson (together, the “Reporting
Persons”).
Item
2(b).
Address of
Principal Business Office or, if None, Residence.
The
Reporting Persons’ business address is:
68 Fiesta Way
Fort Lauderdale, FL 33301
Item
2(c).
Citizenship.
Mr.
John Stetson is a citizen of the United States. HS Contrarian
Investments, LLC is organized under the laws of the state of
Delaware.
Item
2(d).
Title of Class of
Securities.
Common
Stock, par value $0.001
Item
2(e).
CUSIP
Number.
58504H101
Item3.
Type of
Person.
Not
applicable.
Item
4.
Ownership.
(a)
Amount beneficially owned: 1,098,901
(b)
Percent of class: 5.3% (Based on
20,922,634 shares of common stock
outstanding as of July 17, 2017) [1]
(c)
Number of shares as to which the person has:
(i)
Sole power to vote or to direct the vote: 1,098,901
(ii)
Shared power to vote or to direct the vote: 0
(iii)
Sole power to dispose or to direct the disposition of:
1,098,901
(iv)
Shared power to dispose or to direct the disposition of:
0
__________________
[1]
Excludes two
warrants held by John Stetson to purchase an aggregate of 37,929
Shares of the Issuer, two warrants held by Stetson Capital
Investments, Inc. to purchase an aggregate of 95,288 Shares of the
Issuer and a warrant acquired by HS Contrarian Investments, LLC in
this transaction to purchase 549,451 Shares which will become
exercisable in January 2018. The exercise of the aforesaid warrants
is subject to a beneficial ownership limitation in accordance with
which the beneficial holder of the warrants shall not own more than
4.99% of the number of the Shares outstanding immediately after
giving effect to the issuance of the Shares underlying the
warrants. John Stetson is the control person of Stetson Capital
Investments, Inc. and HS Contrarian Investments, LLC.
Item
5.
Ownership of Five
Percent or Less of a Class.
Not
applicable.
Item
6.
Ownership of More
than Five Percent on Behalf of Another Person.
Not
applicable.
Item
7.
Identification and
Classification of the Subsidiary Which Acquired the Security Being
Reported by the Parent Holding Company or Control
Person.
Not
applicable.
Item
8.
Identification and
Classification of Members of the Group.
Not
applicable.
Item
9.
Notice of
Dissolution of Group.
Not
applicable.
Item
10.
Certifications.
By
signing below I certify that, to the best of my knowledge and
belief, the securities referred to above were not acquired and are
not held for the purpose of or with the effect of changing or
influencing the control of the issuer of the securities and were
not acquired and are not held in connection with or as a
participant in any transaction having that purpose or
effect.
SIGNATURE
After
reasonable inquiry and to the best of my knowledge and belief, I
certify that the information set forth in this statement is true,
complete and correct.
| | | | |
| Date:
July 18, 2017 | By: | /s/
John Stetson | |
| | | John
Stetson | |
| | | | |
| | | HS
Contrarian Investments, LLC | |
| Date:
July 18, 2017 | By: | /s/
John Stetson | |
| | | John
Stetson, President | |